secwatch.observer — SEC 8-K summary
======================================

Issuer:     MARIMED INC. (MRMD)
CIK:        0001522767
Form:       8-K
Filed at:   2022-11-07T23:59:59+00:00
Accession:  0001522767-22-000012
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MariMed Q3 revenue $33.9M (+2% YoY); adjusted EBITDA falls 32% to $8.6M
-----------------------------------------------------------------------

- Revenue $33.9M vs $33.2M in Q3 2021, a 2% YoY increase.
- GAAP net income $2.7M, up from $2.1M YoY.
- Non-GAAP adjusted EBITDA $8.6M, down from $12.6M YoY; margin 25% vs 38%.
- Gross margin declined to 48% from 55% YoY.
- CEO cites industry headwinds but highlights strength in retail and wholesale.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1522767/000152276722000012/0001522767-22-000012-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1522767/000152276722000012/mrmd-20221107.htm
  HTML page:      https://secwatch.observer/filing/0001522767-22-000012

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer